Alina Hanf

1.0k total citations
6 papers, 555 citations indexed

About

Alina Hanf is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alina Hanf has authored 6 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alina Hanf's work include Adipokines, Inflammation, and Metabolic Diseases (2 papers), Diabetes Treatment and Management (2 papers) and Cardiovascular Disease and Adiposity (1 paper). Alina Hanf is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (2 papers), Diabetes Treatment and Management (2 papers) and Cardiovascular Disease and Adiposity (1 paper). Alina Hanf collaborates with scholars based in Germany, France and Netherlands. Alina Hanf's co-authors include Andreas Daiber, Thomas Münzel, Matthias Oelze, Huige Li, Swenja Kröller‐Schön, Sebastian Steven, Ning Xia, Karl J. Lackner, Eberhard Schulz and Siyer Roohani and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Molecular Sciences and Cardiovascular Research.

In The Last Decade

Alina Hanf

6 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alina Hanf Germany 6 203 185 145 136 114 6 555
Elena Zinßius Germany 6 279 1.4× 212 1.1× 108 0.7× 135 1.0× 138 1.2× 7 596
Fabrice M A C Martens Netherlands 10 221 1.1× 254 1.4× 200 1.4× 137 1.0× 126 1.1× 25 609
Philipp Welschof Germany 7 429 2.1× 226 1.2× 127 0.9× 228 1.7× 112 1.0× 9 657
Tomohiro Komatsu Japan 16 177 0.9× 212 1.1× 122 0.8× 320 2.4× 58 0.5× 46 689
Maria Dulak‐Lis United Kingdom 7 106 0.5× 126 0.7× 136 0.9× 79 0.6× 164 1.4× 8 494
Takeaki Honda Japan 12 182 0.9× 147 0.8× 273 1.9× 152 1.1× 98 0.9× 15 557
Chao‐Sheng Lo Canada 18 251 1.2× 424 2.3× 196 1.4× 119 0.9× 78 0.7× 34 875
Nicola Schäfer Switzerland 7 120 0.6× 181 1.0× 136 0.9× 161 1.2× 163 1.4× 7 681
Motofumi Sasaki Japan 13 334 1.6× 202 1.1× 139 1.0× 177 1.3× 72 0.6× 16 781

Countries citing papers authored by Alina Hanf

Since Specialization
Citations

This map shows the geographic impact of Alina Hanf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alina Hanf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alina Hanf more than expected).

Fields of papers citing papers by Alina Hanf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alina Hanf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alina Hanf. The network helps show where Alina Hanf may publish in the future.

Co-authorship network of co-authors of Alina Hanf

This figure shows the co-authorship network connecting the top 25 collaborators of Alina Hanf. A scholar is included among the top collaborators of Alina Hanf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alina Hanf. Alina Hanf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
2.
Hanf, Alina, Matthias Oelze, Adrian Manea, et al.. (2019). The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes. Chemico-Biological Interactions. 313. 108834–108834. 48 indexed citations
3.
Daiber, Andreas, Ning Xia, Sebastian Steven, et al.. (2019). New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease. International Journal of Molecular Sciences. 20(1). 187–187. 210 indexed citations
4.
Steven, Sebastian, Matthias Oelze, Alina Hanf, et al.. (2017). The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats. Redox Biology. 13. 370–385. 243 indexed citations
5.
Hanf, Alina, Sebastian Steven, Matthias Oelze, et al.. (2017). The SGLT2 Inhibitor Empagliflozin Improves the Primary Diabetic Complications in ZDF Rats. Free Radical Biology and Medicine. 112. 112–113. 6 indexed citations
6.
Steven, Sebastian, Mobin Dib, Michael Hausding, et al.. (2017). CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db mice. Cardiovascular Research. 114(2). 312–323. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026